Analyst Thomas Shrader from BTIG maintained a Buy rating on Denali Therapeutics (DNLI – Research Report) and keeping the price target at ...

Kymera Therapeutics (KYMR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Vikram ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

Looking ahead, Sarepta Therapeutics has indicated significant developments in its pipeline, particularly concerning its limb-girdle muscular dystrophy (LGMD) portfolio. The company anticipates ...

Notably, we drove important clinical progress of our targeted therapeutics in solid tumors ... advanced our emerging pipeline of novel radiopharmaceuticals and strengthened our financial position ...

New York, USA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Therapeutics Segment ...

Exclusive agreement to acquire Nudge Therapeutics includes their series of cGAS inhibitors. Nudge has developed novel potent small molecule cGAS inhibitors that prevents the overproduction of Type ...

WARREN, N.J., Jan. 13, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today provided an update on the Company's progress and its outlook for 2025. Matthew ...

Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today highlighted its recent pipeline progress and anticipated 2025 milestones.

WARREN, N.J., Jan. 13, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today provided an update on the Company's progress and its outlook for 2025. Matthew B. Klein, M.D., Chief Executive ...

The multiple data updates expected throughout 2025 present significant opportunities for Werewolf Therapeutics to demonstrate the value of its pipeline and PREDATOR platform. Positive results from ...

SAN FRANCISCO--(BUSINESS WIRE)--Marea Therapeutics, Inc., a clinical-stage ... In addition, we announced our second lead pipeline program for the treatment of acromegaly with clinical development ...